Czech National Bank Buys 1,270 Shares of HCA Healthcare, Inc. $HCA

Czech National Bank lifted its stake in shares of HCA Healthcare, Inc. (NYSE:HCA) by 3.1% in the second quarter, according to its most recent filing with the SEC. The fund owned 42,339 shares of the company’s stock after acquiring an additional 1,270 shares during the period. Czech National Bank’s holdings in HCA Healthcare were worth $16,220,000 as of its most recent SEC filing.

A number of other large investors also recently added to or reduced their stakes in HCA. Brighton Jones LLC purchased a new position in HCA Healthcare in the 4th quarter worth $1,021,000. State of Wyoming raised its position in HCA Healthcare by 199.1% in the 4th quarter. State of Wyoming now owns 1,379 shares of the company’s stock worth $414,000 after purchasing an additional 918 shares during the period. Two Sigma Advisers LP purchased a new position in HCA Healthcare in the 4th quarter worth $20,290,000. Twinbeech Capital LP purchased a new position in HCA Healthcare in the 4th quarter worth $3,052,000. Finally, Vident Advisory LLC increased its position in shares of HCA Healthcare by 8.2% in the fourth quarter. Vident Advisory LLC now owns 1,949 shares of the company’s stock valued at $585,000 after acquiring an additional 147 shares during the period. Hedge funds and other institutional investors own 62.73% of the company’s stock.

HCA Healthcare Trading Down 0.8%

Shares of NYSE HCA opened at $399.79 on Wednesday. The company has a debt-to-equity ratio of 69.07, a quick ratio of 0.86 and a current ratio of 0.98. The firm’s 50 day moving average price is $383.82 and its 200-day moving average price is $364.30. HCA Healthcare, Inc. has a 52-week low of $289.98 and a 52-week high of $420.98. The company has a market cap of $93.55 billion, a PE ratio of 16.80, a P/E/G ratio of 1.27 and a beta of 1.41.

HCA Healthcare (NYSE:HCA) last released its quarterly earnings data on Friday, July 25th. The company reported $6.84 earnings per share for the quarter, beating the consensus estimate of $6.20 by $0.64. HCA Healthcare had a net margin of 8.21% and a negative return on equity of 7,363.11%. The firm had revenue of $18.61 billion during the quarter, compared to analysts’ expectations of $18.49 billion. During the same period in the previous year, the company earned $5.50 earnings per share. The firm’s quarterly revenue was up 6.4% on a year-over-year basis. HCA Healthcare has set its FY 2025 guidance at 25.500-27.000 EPS. On average, equities research analysts expect that HCA Healthcare, Inc. will post 24.98 EPS for the current fiscal year.

HCA Healthcare Announces Dividend

The firm also recently announced a quarterly dividend, which will be paid on Tuesday, September 30th. Shareholders of record on Tuesday, September 16th will be issued a dividend of $0.72 per share. This represents a $2.88 dividend on an annualized basis and a yield of 0.7%. The ex-dividend date of this dividend is Tuesday, September 16th. HCA Healthcare’s dividend payout ratio is currently 12.11%.

Insider Activity

In other news, EVP Michael S. Cuffe sold 3,836 shares of the stock in a transaction on Monday, September 8th. The shares were sold at an average price of $418.84, for a total value of $1,606,670.24. Following the completion of the sale, the executive vice president directly owned 31,503 shares of the company’s stock, valued at $13,194,716.52. This represents a 10.85% decrease in their ownership of the stock. The sale was disclosed in a document filed with the SEC, which is available at this hyperlink. 1.30% of the stock is currently owned by company insiders.

Analysts Set New Price Targets

A number of equities analysts have issued reports on the stock. Royal Bank Of Canada decreased their price objective on shares of HCA Healthcare from $404.00 to $401.00 and set an “outperform” rating on the stock in a research report on Monday, July 28th. Wall Street Zen upgraded shares of HCA Healthcare from a “hold” rating to a “buy” rating in a research report on Saturday, July 5th. Robert W. Baird boosted their price objective on shares of HCA Healthcare from $380.00 to $423.00 and gave the company a “neutral” rating in a research report on Thursday, August 14th. Morgan Stanley reduced their price target on shares of HCA Healthcare from $410.00 to $400.00 and set an “equal weight” rating on the stock in a research report on Monday, July 28th. Finally, Cantor Fitzgerald reiterated an “overweight” rating and set a $444.00 price target on shares of HCA Healthcare in a research report on Tuesday, August 26th. One analyst has rated the stock with a Strong Buy rating, seven have assigned a Buy rating and nine have assigned a Hold rating to the stock. According to MarketBeat, HCA Healthcare currently has an average rating of “Moderate Buy” and an average price target of $403.17.

HCA Healthcare Company Profile

HCA Healthcare, Inc, through its subsidiaries, owns and operates hospitals and related healthcare entities in the United States. It operates general and acute care hospitals that offers medical and surgical services, including inpatient care, intensive care, cardiac care, diagnostic, and emergency services; and outpatient services, such as outpatient surgery, laboratory, radiology, respiratory therapy, cardiology, and physical therapy.